Scott Power: Which ASX healthcare stock has soared 30pc this week?
Imricor soared 30% over past five days after VISABL-AFL trial update and licensing deal Vitrafy and Renerve IPOed this week as as momentum returned to ASX healthcare sector ASX health stocks rose 4.3% over past five days, outperforming broader market, …